Risk-stratified management to remove low-risk penicillin allergy labels in the patients with COVID-19 in the intensive care unit is a research paper published in The Journal of Allergy and Clinical Immunology In Practice (2022). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of General Medical Sciences
Grant: 5T32 GM007569-41
Agency for Healthcare Research and Quality
Grant: 1K12HS026395-01
Learning Health System Scholar Program at Vanderbilt
National Center for Advancing Translational Sciences
Grant: R01AI152183
National Center for Advancing Translational Sciences
Grant: R01HG010863
National Center for Advancing Translational Sciences
Grant: R13AR078623
National Center for Advancing Translational Sciences
Grant: U01AI154659
National Center for Advancing Translational Sciences
Grant: UAI109565
National Center for Advancing Translational Sciences
Grant: UL1 TR002243
National Center for Advancing Translational Sciences
Grant: VR52841
National Institutes of Health
Grant: 1R01AI152183-01
Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study)
National Institutes of Health
Grant: 1R01HG010863-01
Genetic risk and long-term outcomes associated with Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in survivors
National Institutes of Health
Grant: 3UM1AI109565-09S1
Immune Tolerance Network
National Institutes of Health
Grant: 5UL1TR002243-05
Vanderbilt Institute for Clinical and Translational Research (VICTR)
National Institutes of Health
Grant: 5T32GM007569-09
CLINICAL PHARMACOLOGY
National Institutes of Health
Grant: 5U01AI154659-04
NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
National Institutes of Health
Grant: 1R13AR078623-01
Stevens-Johnson syndrome/toxic epidermal necrolysis 2021: Collaboration, Innovation and Community
AHRQ HHS
Grant: K12 HS026395
NIAID NIH HHS
Grant: UM1 AI109565
NIGMS NIH HHS
Grant: T32 GM007569
FWCI
2.28
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals